Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Corrigendum to "Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice" [Biomaterials (2016) 63-71].

Author information

Affiliations

  • 1. Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, 430022, PR China.
      Authors
    • Zhang B 1
    • Jiang T 1
    • Deng J 1
    • Shi W 1
    (4 authors)
  • 2. School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, 826 Zhangheng Road, Shanghai, 201203, PR China.
      Authors
    • She XJ 2
    • Shen S 2
    • Wang S 2
    • Pang Z 2
    • Jiang X 2
    (5 authors)
  • 3. Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, 430022, PR China; Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, PR China.
      Authors
    • Mei H 3
    • Hu Y 3
    (2 authors)

ORCIDs linked to this article

Biomaterials, 15 Mar 2021, 271:120744
https://doi.org/10.1016/j.biomaterials.2021.120744 PMID: 33735830 

This corrects "Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice." Biomaterials. 2016 Jul;96:63-71.

Abstract 

No abstract provided.

Full text links 

Read article at publisher's site: https://doi.org/10.1016/j.biomaterials.2021.120744

Citations & impact 

Impact metrics

1
Citation
Jump to Citations

Article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.